AIDS Associated with Severe Cor Pulmonale and Large Pericardial Effusion with Cardiac Tamponade

Cardiology in Review

Volumn 12, Issue 1, 2004, Pages 49-55

  Pai, Rakesh K ^a,b   Kedia, Anita ^a   Hsu, Pamela Y F ^a   Osborn, Larry A ^a   Taylor, Robert A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b Division of Cardiology   (United States)

Author keywords

AIDS; Cardiac tamponade; Cor pulmonale; HIV; HIV related pulmonary hypertension; Pericardial effusion; Primary pulmonary hypertension

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COR PULMONALE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEART TAMPONADE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INCIDENCE; MALE; PATHOGENESIS; PERCUTANEOUS DRAINAGE; PERICARDIAL EFFUSION; PULMONARY HYPERTENSION; SURVIVAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AUTOPSY; CARDIAC TAMPONADE; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FATAL OUTCOME; HUMANS; HYPERTENSION, PULMONARY; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PULMONARY HEART DISEASE;

EID: 0347510813     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000089950.17031.42     Document Type: Article

References (19)

1. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation. 2002;106:1420-1425.
2. Pelicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology. 2001;52:31-41.
3. Mesa RA, Edell ES, Dunn WD, et al. Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc. 1998;73:37-45.
4. Mehta NJ, Khan IA, Mehta RN, et al. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest. 2001;118:1133-1141.
5. Pellicelli AM, Palmieri F, D'Ambrosio C, et al. Role of human immunodeficiency virus in primary pulmonary hypertension. Angiology. 1998;49:1005-1011.
6. Speich R, Jenni R, Opravil M, et al. Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy. Swiss Med Wkly. 2001;131:663-665.
7. Aguilar RV, Farber HW. Epoprostenol therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care. 2000;162:967-970.
8. Heidenreich PA, Eisenberg MJ, Kee LL, et al. Pericardial effusion in AIDS: incidence and survival. Circulation. 1995;92:3229-3234.
9. Chen Y, Brennessel D, Walters J, et al. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J. 1999;137:516-521.
10. Barbaro G, Fisher SD, Lipshultz SE. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis. 2001;1:115-124.
11. Barbaro G, Klatt EC. HIV infection and the cardiovascular system. AIDS Rev. 2002;4:93-103.
12. Cotter B. Epidemiology of HIV cardiac disease. Prog Cardiovasc Dis. 2003;45:319-326.
13. Galie N, Manes A, Uguccioni L, et al. Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest. 1998;114(3 suppl):184S-194S.
14. Chen Y, Brennessel D, Johnson M, et al. Pericardial effusion in acquired immunodeficiency disease. Arch Intern Med. 2000;160:2397-2398.
15. Katz AS, Sadaniantz A. Echocardiography in HIV cardiac disease. Prog Cardiovasc Dis. 2003;45:285-292.
16. Pellicelli AM, Palmieri F, Cicalini S, et al. Pathogenesis of HIV-related pulmonary hypertension. Ann N Y Acad Sci. 2001;946:82-94.
17. Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation. 1994;89:2722-2727.
18. Petrosillo N, Pellicelli AM, Boumis E, et al. Clinical manifestation of HIV-related pulmonary hypertension. Ann N Y Acad Sci. 2001;946:223-235.
19. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-117.